Fig. 1From: Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcomeRepresentative images of RBM3 immunostaining in oesophageal cancer. The image shows low and high RBM3 immunostaining in EACs (a and b) and ESCCs (c and d). Image of RBM3 immunostaining in benign squamous esophageal tissue (e)Back to article page